{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:18:35Z","timestamp":1790979515843,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.jneuroim.2009.02.007","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T04:59:18Z","timestamp":1236661158000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Human African trypanosomiasis, chemotherapy and CNS disease"],"prefix":"10.1016","volume":"211","author":[{"given":"Jean","family":"Rodgers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2009.02.007_bib1","series-title":"An Introduction to Neuropathology","first-page":"94","article-title":"Virus and other infections","author":"Adams","year":"1998"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2990.1986.tb00682.x","article-title":"Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy","volume":"12","author":"Adams","year":"1986","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pt.2008.05.010","article-title":"Contributions of experimental mouse models to the understanding of African trypanosomiasis","volume":"24","author":"Antoine-Moussiaux","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib4","series-title":"The African Trypanosomiases","first-page":"661","article-title":"Clinical manifestations and diagnosis of sleeping sickness","author":"Apted","year":"1970"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib5","series-title":"Infectious Diseases of the Nervous System","first-page":"321","article-title":"Neurological aspects of human African trypanosomiasis","author":"Atouguia","year":"2000"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2471\/BLT.06.031955","article-title":"Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo","volume":"84","author":"Balasegaram","year":"2006","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2471\/BLT.05.028399","article-title":"Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo","volume":"84","author":"Balasegaram","year":"2006","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(01)00655-4","article-title":"Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness","volume":"193","author":"Bisser","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"Supp 1","key":"10.1016\/j.jneuroim.2009.02.007_bib10","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the treatment of human African trypanosomiasis","volume":"90","author":"Burri","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib11","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(00)02141-3","article-title":"Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial","volume":"355","author":"Burri","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0035-9203(37)90074-9","article-title":"The pathology of the brain in Rhodesian trypanosomiasis","volume":"30","author":"Calwell","year":"1937","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1086\/432576","article-title":"Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis","volume":"41","author":"Chappuis","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.39505.490544.BE","article-title":"African sleeping sickness","volume":"336","author":"Checchi","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijpara.2006.04.011","article-title":"A link between chemokine levels and disease severity in human African trypanosomiasis","volume":"36","author":"Courtioux","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4269\/ajtmh.1996.55.586","article-title":"The efficacy of pentamidine in the treatment of early\u2013late stage Trypanosoma brucei gambiense trypanosomiasis","volume":"55","author":"Doua","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1383-5769(00)00065-9","article-title":"Cytokines and the acute phase response in post-treatment reactive encephalopathy of Trypanosoma brucei brucei infected mice","volume":"50","author":"Eckersall","year":"2001","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib18","first-page":"206","article-title":"Meningoencephalitis in chronic Trypanosoma brucei rhodesiense infection of the white mouse","volume":"30","author":"Fink","year":"1979","journal-title":"Tropenmed. Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/13550280802282934","article-title":"Traversal of human and animal trypanosomes across the blood-brain barrier","volume":"14","author":"Grab","year":"2008","journal-title":"J. Neurovirology"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1645\/GE-287R","article-title":"African trypanosome interactions with an in vitro model of the human blood-brain barrier","volume":"90","author":"Grab","year":"2004","journal-title":"J. Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-5728(92)90040-R","article-title":"Immunopathology in central nervous system human African trypanosomiasis","volume":"36","author":"Hunter","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib22","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1128\/iai.59.12.4636-4640.1991","article-title":"Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice","volume":"59","author":"Hunter","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0140-6736(92)91531-C","article-title":"Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis","volume":"339","author":"Hunter","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib24","first-page":"635","article-title":"Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice","volume":"67","author":"Hunter","year":"1992","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-5728(92)90064-R","article-title":"Correlation of autoantibody titres with central nervous system pathology in experimental African trypanosomiasis","volume":"41","author":"Hunter","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/path.1700770224","article-title":"The lesions produced in the central nervous system by certain organic arsenical compounds","volume":"77","author":"Hurst","year":"1959","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib27","first-page":"190","article-title":"Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO)","volume":"46","author":"Iten","year":"1995","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0035-9203(89)90272-1","article-title":"Trypanosomiasis and encephalitis: possible aetiology and treatment","volume":"83","author":"Jennings","year":"1989","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2990.1997.tb01206.x","article-title":"The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis","volume":"23","author":"Jennings","year":"1997","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1383-5769(02)00044-2","article-title":"Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen","volume":"51","author":"Jennings","year":"2002","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(99)00196-4","article-title":"The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis","volume":"100","author":"Kennedy","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","article-title":"Human African trypanosomiasis of the CNS: current issues and challenges","volume":"113","author":"Kennedy","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijpara.2006.01.012","article-title":"Diagnostic and neuropathogenesis issues in human African trypanosomiasis","volume":"36","author":"Kennedy","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.trstmh.2008.08.013","article-title":"Cytokines in central nervous system trypanosomiasis: cause, effect or both?","volume":"103","author":"Kennedy","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.trstmh.2007.11.011","article-title":"Diagnosing central nervous system trypanosomiasis: two stage or not to stage?","volume":"102","author":"Kennedy","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.21429","article-title":"The continuing problem of human African trypanosomiasis (sleeping sickness)","volume":"64","author":"Kennedy","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib37","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1073\/pnas.94.8.4167","article-title":"A substance P antagonist, RP-67, 580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei","volume":"94","author":"Kennedy","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib38","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/brain\/awg160","article-title":"Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice","volume":"126","author":"Kennedy","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1172\/JCI110035","article-title":"Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis","volume":"67","author":"Lambert","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1473-3099(02)00321-3","article-title":"Treatment of human African trypanosomiasis\u2013present situation and needs for research and development","volume":"2","author":"Legros","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0035-9203(02)90115-X","article-title":"Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment","volume":"96","author":"Lejon","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2003.08.033","article-title":"Neuro-inflammatory risk factors for treatment failure in \u201cearly second stage\u201d sleeping sickness patients treated with pentamidine","volume":"144","author":"Lejon","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib43","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1086\/374645","article-title":"Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis","volume":"187","author":"Lejon","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/588668","article-title":"Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis","volume":"47","author":"Lejon","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib45","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1086\/323479","article-title":"Nitric oxide and cytokine synthesis in human African trypanosomiasis","volume":"184","author":"MacLean","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.trstmh.2005.03.013","article-title":"Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients","volume":"100","author":"MacLean","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib47","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1086\/522011","article-title":"Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response","volume":"196","author":"MacLean","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI22104","article-title":"Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier","volume":"114","author":"Masocha","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib49","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1128\/AAC.50.5.1798-1804.2006","article-title":"Minocycline impedes African trypanosome invasion of the brain in a murine model","volume":"50","author":"Masocha","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.physbeh.2007.05.045","article-title":"Migration of African trypanosomes across the blood-brain barrier","volume":"92","author":"Masocha","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib51","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-3083.2008.02170.x","article-title":"Differential invasion of Trypanosoma brucei brucei and lymphocytes into the brain of C57BL\/6 and 129Sv\/Ev mice","volume":"68","author":"Masocha","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib52","first-page":"103","article-title":"Pathology of infection with Trypanosoma brucei: disease syndromes in dogs and cattle resulting from severe tissue damage","volume":"7","author":"Morrison","year":"1983","journal-title":"Contrib. Microbiol. Immunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib53","first-page":"581","article-title":"Histological observations on the changes in the nervous system in trypanosome infections especially sleeping sickness and their relation to syphilitic lesions of the nervous system","volume":"3","author":"Mott","year":"1907","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.0305-1846.2001.00306.x","article-title":"Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model","volume":"27","author":"Mulenga","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib55","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI27798.","article-title":"Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease","volume":"116","author":"Nikolskaia","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijpara.2006.01.011","article-title":"Entry of Trypanosoma brucei gambiense into microvascular endothelial cells of the human blood-brain barrier","volume":"36","author":"Nikolskaia","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib57","first-page":"369","article-title":"Sleeping sickness and the central nervous system","volume":"6","author":"Pentreath","year":"1994","journal-title":"Onderstepoort J. Vet. Res."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib58","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0035-9203(91)90032-T","article-title":"African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis","volume":"85","author":"Pepin","year":"1991","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"Pepin","year":"1994","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib60","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0140-6736(89)92340-4","article-title":"Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness","volume":"1","author":"Pepin","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0035-9203(89)90270-8","article-title":"An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire","volume":"83","author":"Pepin","year":"1989","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib62","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0035-9203(92)90298-Q","article-title":"High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire","volume":"86","author":"Pepin","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/00034983.1994.11812911","article-title":"Blood-brain barrier damage in experimental African trypanosomiasis","volume":"88","author":"Philip","year":"1994","journal-title":"Ann. Trop. Med. Parasit."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib64","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0035-9203(80)90183-2","article-title":"Immunopathological and chemotherapeutic studies in experimental trypanosomiaisis with special reference to the heart and brain","volume":"74","author":"Poltera","year":"1980","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib65","first-page":"205","article-title":"Trypanosoma brucei gambiense: cerebral immunopathology in mice","volume":"39","author":"Poltera","year":"1982","journal-title":"Acta Trop."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib66","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0035-9203(85)90086-0","article-title":"Immunopathological aspects of trypanosomal meningoencephalitis in vervet monkeys after relapse following Berenil treatment","volume":"79","author":"Poltera","year":"1985","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib67","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox\u2013eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo","volume":"45","author":"Priotto","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib68","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.39485.592674.BE","article-title":"Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study","volume":"336","author":"Priotto","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0165-5728(03)00122-X","article-title":"Intraventricular infusion of antagonists of IL-1 and TNF alpha attenuates neurodegeneration induced by the infection of Trypanosoma brucei","volume":"138","author":"Quan","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib70","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.parint.2007.06.008","article-title":"Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis","volume":"56","author":"Rodgers","year":"2007","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib71","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1471-4159.2008.05706.x","article-title":"The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain","volume":"107","author":"Sanderson","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib72","series-title":"The Pathogenesis of Trypanosomiasis of the CNS. Studies on Parasitological and Neurohistological Findings in Trypanosoma Rhodesiense Infected Vervet Monkeys","first-page":"333","volume":"vol. 399","author":"Schmidt","year":"1983"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jnr.490210109","article-title":"Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia","volume":"21","author":"Schultzberg","year":"1988","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib74","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(99)00238-6","article-title":"Chemokines are produced in the brain early during the course of experimental African trypanosomiasis","volume":"103","author":"Sharafeldin","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2005.06.017","article-title":"Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology","volume":"167","author":"Sternberg","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.02.007_bib76","series-title":"Control and Surveillance of African Trypanosomiaisis","first-page":"1","volume":"vol. 881","author":"WHO","year":"1998"},{"key":"10.1016\/j.jneuroim.2009.02.007_bib77","first-page":"71","article-title":"Human African trypanosomiasis (sleeping sickness): epidemiological update","volume":"81","author":"WHO","year":"2006","journal-title":"Wkly. Epidemiol. Rec."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:57Z","timestamp":1759047057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":77,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0165572809000617"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.02.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human African trypanosomiasis, chemotherapy and CNS disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}